Assembly Biosciences (ASMB) Change in Cash (2010 - 2026)

Assembly Biosciences' Change in Cash history runs 17 years deep, the most recent figure standing at -$27.3 million for Q1 2026.

• In Q1 2026, Change in Cash fell 83.04% year-over-year to -$27.3 million; the TTM figure through Mar 2026 stood at $7.7 million (up 65.24% YoY), while the FY2025 annual figure was $20.1 million, up 8.66% from the prior year.
• Change in Cash for Q1 2026 stood at -$27.3 million, down from $35.9 million in the prior quarter.
• The five-year high for Change in Cash was $35.9 million in Q4 2025, with the low at -$27.3 million in Q1 2026.
• The 5-year median for Change in Cash is -$1.1 million (2024), against an average of -$853352.9.
• Peak annual rise in Change in Cash reached 263.08% in 2025, while the deepest fall reached 1267.31% in 2025.
• Assembly Biosciences' Change in Cash stood at -$2.3 million in 2022, then slumped by 202.22% to -$6.8 million in 2023, then surged by 245.15% to $9.9 million in 2024, then surged by 263.08% to $35.9 million in 2025, then plunged by 176.09% to -$27.3 million in 2026.
• Business Quant data shows ASMB's Change in Cash at -$27.3 million in Q1 2026, $35.9 million in Q4 2025, and -$1.5 million in Q3 2025.